Annual ROE
-50.40%
+208.04%+80.50%
December 31, 2024
Summary
- As of March 12, 2025, DYN annual return on equity is -50.40%, with the most recent change of +208.04% (+80.50%) on December 31, 2024.
- During the last 3 years, DYN annual ROE has fallen by -9.85% (-24.29%).
- DYN annual ROE is now -151.11% below its all-time high of 98.61%, reached on December 31, 2018.
Performance
DYN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-49.05%
+8.41%+14.64%
December 31, 2024
Summary
- As of March 12, 2025, DYN quarterly return on equity is -49.05%, with the most recent change of +8.41% (+14.64%) on December 31, 2024.
- Over the past year, DYN quarterly ROE has increased by +19.80% (+28.76%).
- DYN quarterly ROE is now -131.91% below its all-time high of -21.15%, reached on September 30, 2020.
Performance
DYN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
DYN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +80.5% | +28.8% |
| 3 y3 years | -24.3% | +38.4% |
| 5 y5 years | +52.4% | +38.4% |
DYN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.3% | +80.5% | -40.7% | +64.0% |
| 5 y | 5-year | -190.3% | +80.5% | -131.9% | +64.1% |
| alltime | all time | -151.1% | +80.5% | -131.9% | +64.1% |
Dyne Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -50.40%(-80.5%) | -49.05%(-14.6%) |
| Sep 2024 | - | -57.46%(-16.5%) |
| Jun 2024 | - | -68.85%(-37.9%) |
| Mar 2024 | - | -110.92%(-18.7%) |
| Dec 2023 | -258.44%(+288.0%) | -136.35%(+39.7%) |
| Sep 2023 | - | -97.57%(+22.5%) |
| Jun 2023 | - | -79.63%(+16.2%) |
| Mar 2023 | - | -68.55%(+14.7%) |
| Dec 2022 | -66.61% | -59.74%(+2.4%) |
| Sep 2022 | - | -58.34%(+12.5%) |
| Jun 2022 | - | -51.86%(+27.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -40.70%(+16.8%) |
| Dec 2021 | -40.55%(+133.6%) | -34.86%(+16.5%) |
| Sep 2021 | - | -29.91%(+25.8%) |
| Jun 2021 | - | -23.78%(+2.5%) |
| Mar 2021 | - | -23.19%(+9.5%) |
| Dec 2020 | -17.36%(-83.6%) | -21.18%(+0.1%) |
| Sep 2020 | - | -21.15%(-44.9%) |
| Jun 2020 | - | -38.41%(-71.9%) |
| Mar 2020 | - | -136.51%(+70.0%) |
| Dec 2019 | -105.86%(-207.4%) | -80.32% |
| Dec 2018 | 98.61% | - |
FAQ
- What is Dyne Therapeutics annual return on equity?
- What is the all time high annual ROE for Dyne Therapeutics?
- What is Dyne Therapeutics annual ROE year-on-year change?
- What is Dyne Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly ROE year-on-year change?
What is Dyne Therapeutics annual return on equity?
The current annual ROE of DYN is -50.40%
What is the all time high annual ROE for Dyne Therapeutics?
Dyne Therapeutics all-time high annual return on equity is 98.61%
What is Dyne Therapeutics annual ROE year-on-year change?
Over the past year, DYN annual return on equity has changed by +208.04% (+80.50%)
What is Dyne Therapeutics quarterly return on equity?
The current quarterly ROE of DYN is -49.05%
What is the all time high quarterly ROE for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly return on equity is -21.15%
What is Dyne Therapeutics quarterly ROE year-on-year change?
Over the past year, DYN quarterly return on equity has changed by +19.80% (+28.76%)